Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|May 2, 2022
1.5T MR-Guided Daily Adaptive Stereotactic Body Radiotherapy for Prostate Re-Irradiation: A Preliminary Report of Toxicity and Clinical OutcomesFrancesco Cuccia, Michele Rigo, Vanessa Figlia, et al.
Radiation Oncology (London, England)|July 24, 2020
Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapyFrancesco Cuccia, Rosario Mazzola, Luca Nicosia, et al.
Breast Care (Basel, Switzerland)|October 4, 2021
Mammary Chain Irradiation in Left-Sided Breast Cancer: Can We Reduce the Risk of Secondary Cancer and Ischaemic Heart Disease with Modern Intensity-Modulated Radiotherapy Techniques?Vanessa Figlia, Cristoforo Simonetto, Markus Eidemüller, et al.
Technology in Cancer Research & Treatment|January 27, 2025
MR-Guided Adaptive Radiotherapy in Localized Prostate CancerAndrea Gaetano Allegra, Luca Nicosia, Michele Rigo, et al.
Journal of Cancer Research and Clinical Oncology|July 16, 2021
Mitigation on bowel loops daily variations by 1.5-T MR-guided daily-adaptive SBRT for abdomino-pelvic lymph-nodal oligometastasesFrancesco Cuccia, Michele Rigo, Davide Gurrera, et al.
The British Journal of Radiology|July 20, 2021
Impact of hydrogel peri-rectal spacer insertion on seminal vesicles intrafraction motion during 1.5 T-MRI-guided adaptive stereotactic body radiotherapy for localized prostate cancerRosario Mazzola, Gianluisa Sicignano, Francesco Cuccia, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 22, 2020
Adaptive SBRT by 1.5 T MR-linac for prostate cancer: On the accuracy of dose delivery in view of the prolonged session timeRuggero Ruggieri, Michele Rigo, Stefania Naccarato, et al.
La Radiologia Medica|April 9, 2021
Stereotactic body radiotherapy for oligometastatic castration sensitive prostate cancer using 1.5 T MRI-Linac: preliminary data on feasibility and acute patient-reported outcomesRosario Mazzola, Francesco Cuccia, Vanessa Figlia, et al.
Journal of Personalized Medicine|December 23, 2022
1.5T MR-Guided Daily-Adaptive SBRT for Prostate Cancer: Preliminary Report of Toxicity and Quality of Life of the First 100 PatientsFilippo Alongi, Michele Rigo, Vanessa Figlia, et al.
Cancers|June 26, 2025
The Clinical Feasibility and Safety of 1.5 T MR-Guided Daily Adapted Radiotherapy in 1000 Patients: A Real-World Large Experience of an Early-Adopter CenterChiara De-Colle, Michele Rigo, Andrea Gaetano Allegra, et al.
Pageof 9